BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37773924)

  • 1. Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis.
    Taylor MR; Cole SW; Strom J; Brazauskas R; Baker KS; Phelan R; Buchbinder D; Hamilton B; Schoemans H; Shaw BE; Sharma A; Bhatt NS; Badawy SM; Winestone LE; Preussler JM; Mayo S; Jamani K; Nishihori T; Lee MA; Knight JM
    Blood Adv; 2023 Nov; 7(22):6830-6838. PubMed ID: 37773924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.
    Knight JM; Rizzo JD; Logan BR; Wang T; Arevalo JM; Ma J; Cole SW
    Clin Cancer Res; 2016 Jan; 22(1):69-78. PubMed ID: 26286914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
    Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
    Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients.
    Shaw BE; Flynn KE; He N; Cusatis R; D'Souza A; Hamilton BK; Horowitz MM; Mattila D; Phelan R; Lee SJ; Brazauskas R
    Cancer; 2024 May; 130(10):1826-1835. PubMed ID: 38198511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia.
    Knight JM; Rizzo JD; Wang T; He N; Logan BR; Spellman SR; Lee SJ; Verneris MR; Arevalo JMG; Cole SW
    JNCI Cancer Spectr; 2019 Dec; 3(4):pkz073. PubMed ID: 31763620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
    Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
    Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Controlled Trial of Isha Kriya versus Observation to Improve Quality of Life in Hematopoietic Cell Transplantation Recipients.
    Chopra M; Naik RR; Naik R; Sahni J; Bala K; Ahlawat J; Anand A; Singh C; Jandial A; Jain A; Prakash G; Khadwal A; Malhotra P; Lad DP
    Transplant Cell Ther; 2023 Aug; 29(8):530.e1-530.e5. PubMed ID: 37192731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.
    Knight JM; Rizzo JD; Hari P; Pasquini MC; Giles KE; D'Souza A; Logan BR; Hamadani M; Chhabra S; Dhakal B; Shah N; Sriram D; Horowitz MM; Cole SW
    Blood Adv; 2020 Feb; 4(3):467-476. PubMed ID: 32027744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological well-being and gene expression in Korean adults: The role of age.
    Lee SH; Choi I; Choi E; Lee M; Kwon Y; Oh B; Cole SW
    Psychoneuroendocrinology; 2020 Oct; 120():104785. PubMed ID: 32622293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loneliness, eudaimonia, and the human conserved transcriptional response to adversity.
    Cole SW; Levine ME; Arevalo JM; Ma J; Weir DR; Crimmins EM
    Psychoneuroendocrinology; 2015 Dec; 62():11-7. PubMed ID: 26246388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
    Mathanda RR; Hamilton BK; Rybicki L; Advani AS; Colver A; Dabney J; Ferraro C; Hanna R; Kalaycio M; Lawrence C; McLellan L; Sobecks R; Majhail NS; Rotz SJ
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1505-1510. PubMed ID: 32439476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes.
    Cusatis RN; Tecca HR; D'Souza A; Shaw BE; Flynn KE
    Cancer; 2020 Jun; 126(11):2679-2686. PubMed ID: 32154926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in eudaimonic well-being and the conserved transcriptional response to adversity in younger breast cancer survivors.
    Boyle CC; Cole SW; Dutcher JM; Eisenberger NI; Bower JE
    Psychoneuroendocrinology; 2019 May; 103():173-179. PubMed ID: 30703712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
    Lin C; Sajeev G; Stiff PJ; Brunstein CG; Cutler C; Sanz G; Lindemans CA; Rezvani AR; Hanna R; Koh LP; Maziarz RT; Hwang WYK; Song Y; Liu Q; Manghani R; Sivaraman S; Signorovitch J; Horwitz ME; Sung AD
    Transplant Cell Ther; 2023 Jan; 29(1):52.e1-52.e9. PubMed ID: 36179986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life 5 or more years post-autologous hematopoietic stem cell transplant.
    Byar KL; Eilers JE; Nuss SL
    Cancer Nurs; 2005; 28(2):148-57. PubMed ID: 15815185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
    Hong S; Brazauskas R; Hebert KM; Ganguly S; Abdel-Azim H; Diaz MA; Beattie S; Ciurea SO; Szwajcer D; Badawy SM; Gratwohl AA; LeMaistre C; Aljurf MDSM; Olsson RF; Bhatt NS; Farhadfar N; Yared JA; Yoshimi A; Seo S; Gergis U; Beitinjaneh AM; Sharma A; Lazarus H; Law J; Ulrickson M; Hashem H; Schoemans H; Cerny J; Rizzieri D; Savani BN; Kamble RT; Shaw BE; Khera N; Wood WA; Hashmi S; Hahn T; Lee SJ; Rizzo JD; Majhail NS; Saber W
    Cancer; 2021 Feb; 127(4):609-618. PubMed ID: 33085090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
    Auletta JJ; Kou J; Chen M; Bolon YT; Broglie L; Bupp C; Christianson D; Cusatis RN; Devine SM; Eapen M; Hamadani M; Hengen M; Lee SJ; Moskop A; Page KM; Pasquini MC; Perez WS; Phelan R; Riches ML; Rizzo JD; Saber W; Spellman SR; Stefanski HE; Steinert P; Tuschl E; Yusuf R; Zhang MJ; Shaw BE
    Transplant Cell Ther; 2023 Jun; 29(6):346.e1-346.e10. PubMed ID: 36924931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
    Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
    Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018.
    Valcarcel B; Schonfeld SJ; Meyer CL; Brunson A; Cooley JJP; Abrahão R; Wun T; Auletta JJ; Gadalla SM; Engels E; Albert PS; Spellman SR; Rizzo JD; Shaw BE; Muffly L; Keegan THM; Morton LM
    Transplant Cell Ther; 2024 Feb; 30(2):239.e1-239.e11. PubMed ID: 37981238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Promoting Resilience in Stress Management (PRISM) intervention for adolescents and young adults receiving hematopoietic cell transplantation: a randomized controlled trial protocol.
    Fladeboe KM; Scott S; Comiskey L; Zhou C; Yi-Frazier JP; Rosenberg AR
    BMC Palliat Care; 2022 May; 21(1):82. PubMed ID: 35585525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.